Short Interest in Nukkleus Inc. (NASDAQ:DFNS) Decreases By 48.2%

Nukkleus Inc. (NASDAQ:DFNS) was the recipient of a significant decrease in short interest in August. As of August 14th, there was short interest totaling 144,490 shares, a decrease of 48.2% from the July 30th total of 279,125 shares. Based on an average daily trading volume, of 2,406,740 shares, the short-interest ratio is presently 0.1 days. Currently, 16.1% of the shares of the company are sold short.

Analysts Set New Price Targets

DFNS has been the subject of a number of recent analyst reports. Noble Financial raised shares of Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. Wall Street Zen raised shares of Nukkleus from a “strong sell” rating to a “sell” rating in a research note on Sunday, August 23rd. Finally, Weiss Ratings cut Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Institutional Trading of Nukkleus

Institutional investors have recently modified their holdings of the stock. BNP Paribas Financial Markets acquired a new position in shares of Nukkleus during the 2nd quarter worth about $56,000. State Street Corp boosted its holdings in Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after buying an additional 7,400 shares during the last quarter. Price T Rowe Associates Inc. MD purchased a new stake in Nukkleus during the 4th quarter worth approximately $57,000. GM Advisory Group LLC purchased a new stake in Nukkleus during the 4th quarter worth approximately $56,000. Finally, Millennium Management LLC purchased a new stake in Nukkleus during the 4th quarter worth approximately $60,000. Institutional investors and hedge funds own 12.47% of the company’s stock.

Nukkleus Price Performance

Shares of DFNS stock traded down $0.52 during trading hours on Friday, hitting $12.19. 577,571 shares of the company’s stock were exchanged, compared to its average volume of 2,418,921. The company has a quick ratio of 0.11, a current ratio of 0.14 and a debt-to-equity ratio of 0.07. The firm has a market cap of $12.31 million, a P/E ratio of -0.03 and a beta of -5.80. The firm has a 50 day moving average of $23.58 and a two-hundred day moving average of $81.54. Nukkleus has a fifty-two week low of $3.70 and a fifty-two week high of $1,948.75.

Nukkleus (NASDAQ:DFNS) last released its quarterly earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.11) by ($170.69). The company had revenue of $4.00 million for the quarter, compared to analysts’ expectations of $4.50 million. Sell-side analysts forecast that Nukkleus will post -3.9 EPS for the current year.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.